Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Parker

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2010
The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancerGary J R Cook, Ram Venkitaraman, Aslam S Sohaib, et al.
European Urology|October 21, 2015
Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance CohortDaniel R Henderson, Nandita M de Souza, Karen Thomas, et al.
Frontiers in Oncology|June 3, 2022
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer-Prevalence and Current Clinical PracticePriyanka H Patel, Nina Tunariu, Daniel S Levine, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2007
A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapyHelen A McNair, Vibeke N Hansen, Christopher C Parker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2026
Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?Glen M Blake, Ricardo Donners, Amelia E B Moore, et al.
European Urology Oncology|June 28, 2020
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's "M1|RT Comparison"Adnan Ali, Alex P Hoyle, Christopher C Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT TrialPeter Meidahl Petersen, Adrian D Cook, Matthew R Sydes, et al.
JAMA Oncology|February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAdnan Ali, Alex Hoyle, Áine M Haran, et al.
BJU International|January 23, 2016
Prostate-specific antigen patterns in US and European populations: comparison of six diverse cohortsAndrew J Simpkin, Jenny L Donovan, Kate Tilling, et al.
European Urology|March 4, 2019
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysisSarah Burdett, Liselotte M Boevé, Fiona C Ingleby, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2010
The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancerGary J R Cook, Ram Venkitaraman, Aslam S Sohaib, et al.
European Urology|October 21, 2015
Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance CohortDaniel R Henderson, Nandita M de Souza, Karen Thomas, et al.
Frontiers in Oncology|June 3, 2022
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer-Prevalence and Current Clinical PracticePriyanka H Patel, Nina Tunariu, Daniel S Levine, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2007
A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapyHelen A McNair, Vibeke N Hansen, Christopher C Parker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2026
Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?Glen M Blake, Ricardo Donners, Amelia E B Moore, et al.
European Urology Oncology|June 28, 2020
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's "M1|RT Comparison"Adnan Ali, Alex P Hoyle, Christopher C Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT TrialPeter Meidahl Petersen, Adrian D Cook, Matthew R Sydes, et al.
JAMA Oncology|February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAdnan Ali, Alex Hoyle, Áine M Haran, et al.
BJU International|January 23, 2016
Prostate-specific antigen patterns in US and European populations: comparison of six diverse cohortsAndrew J Simpkin, Jenny L Donovan, Kate Tilling, et al.
European Urology|March 4, 2019
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysisSarah Burdett, Liselotte M Boevé, Fiona C Ingleby, et al.
Pageof 6